193 related articles for article (PubMed ID: 7517763)
1. Nucleolar organizer regions and PCNA expression in prostatic cancers.
Kawase N; Shiokawa A; Ota H; Saitoh T; Yoshida H; Kazama K
Pathol Int; 1994 Mar; 44(3):213-22. PubMed ID: 7517763
[TBL] [Abstract][Full Text] [Related]
2. Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF.
Sakr WA; Sarkar FH; Sreepathi P; Drozdowicz S; Crissman JD
Prostate; 1993; 22(2):147-54. PubMed ID: 7681206
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer.
Nakae S; Nakamura T; Ikegawa R; Yoshioka H; Shirono J; Tabuchi Y
J Surg Oncol; 1998 Sep; 69(1):28-35. PubMed ID: 9762888
[TBL] [Abstract][Full Text] [Related]
4. Silver-stained nucleolar organizer regions in the differentiation of prostatic hyperplasia, intraepithelial neoplasia, and adenocarcinoma.
Cheville JC; Clamon GH; Robinson RA
Mod Pathol; 1990 Sep; 3(5):596-8. PubMed ID: 1700418
[TBL] [Abstract][Full Text] [Related]
5. Assessment of proliferative activity by AgNOR and PCNA in prostatic tissues of ram lambs implanted with zeranol.
Gulbahar MY; Yuksel H; Guvenc T; Okut H
Reprod Domest Anim; 2005 Oct; 40(5):468-74. PubMed ID: 16149954
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between the nucleolar organizer region in adenocarcinoma of the prostate and the Gleason system].
Sentinelli S; Pizzuti V; Rondanelli E; Viggiani F; Paolini R
Pathologica; 1992; 84(1089):49-55. PubMed ID: 1379709
[TBL] [Abstract][Full Text] [Related]
7. Silver-binding nucleolar organizer regions in benign and malignant prostatic lesions.
Pavlakis K; Alivizatos G; Mitropoulos D; Constantinides C; Skopelitou A; Kittas C; Dimopoulos C
Urol Int; 1992; 49(3):137-40. PubMed ID: 1281586
[TBL] [Abstract][Full Text] [Related]
8. Progressive activity in latent prostate carcinoma defined by argyrophilic staining of the nucleolar organizer regions (AgNOR).
Konishi N; Nakaoka S; Tsuzuki T; Kitahori Y; Nishii K; Kitamura M; Ohshima M; Hiasa Y
Pathol Int; 1994 Apr; 44(4):297-302. PubMed ID: 7519105
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen and nucleolar organizer region for differential diagnosis of dysplasia and adenocarcinoma in gastric biopsies.
Ozercan IH; Bahçecioglu IH; Ozercan MR; Bozlak N; Dogan C; Yekeler H
Indian J Gastroenterol; 2000; 19(2):57-60. PubMed ID: 10812815
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar organiser regions in hyperplastic and neoplastic prostatic tissue.
Hansen AB; Ostergård B
Virchows Arch A Pathol Anat Histopathol; 1990; 417(1):9-13. PubMed ID: 1694333
[TBL] [Abstract][Full Text] [Related]
11. Nucleolar organizer regions as discriminators for the diagnosis of well-differentiated adenocarcinoma of the prostate.
Schned AR
Arch Pathol Lab Med; 1993 Oct; 117(10):1000-4. PubMed ID: 8215819
[TBL] [Abstract][Full Text] [Related]
12. Silver staining of nucleolar organizer regions in prostatic lesions.
Ghazizadeh M; Sasaki Y; Oguro T; Aihara K
Histopathology; 1991 Oct; 19(4):369-72. PubMed ID: 1718838
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of proliferating cell nuclear antigen (PCNA) and argyrophilic nucleolar organizer region (AgNOR) in testicular tumors].
Ohyama C; Ito A; Tokuyama S; Nakazumi H; Suzuki K; Kawamura S; Sato M; Saito S; Yoshikawa K; Hoshi S
Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1543-51. PubMed ID: 7474604
[TBL] [Abstract][Full Text] [Related]
14. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
Zhao T; Zhang YL; Li CD
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
[TBL] [Abstract][Full Text] [Related]
15. Nucleolar organizer regions (NOR) in hyperplastic and neoplastic prostate disease.
Deschênes J; Weidner N
Am J Surg Pathol; 1990 Dec; 14(12):1148-55. PubMed ID: 2252105
[TBL] [Abstract][Full Text] [Related]
16. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas.
Mikou P; Kanavaros P; Aninos D; Tzardi M; Karameris A; Gorgoulis B; Papadopoulos N; Lavergne A; Galian A
Pathol Res Pract; 1993 Nov; 189(9):1004-9. PubMed ID: 7905623
[TBL] [Abstract][Full Text] [Related]
17. Nucleolar organizer regions in benign and malignant prostatic disease.
Lloyd SN; Johnson CP; Brown IL; Kirk D
Histopathology; 1991 May; 18(5):449-52. PubMed ID: 1715842
[TBL] [Abstract][Full Text] [Related]
18. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the biological malignancy in hepatocellular carcinoma by argyrophilic nucleolar organizer region (AgNOR) staining--morphological study of AgNOR using image analyzer].
Shiro T; Seki T; Naitoh Y; Nakagawa T; Wakabayashi M; Itoh T; Shiozaki Y; Inoue K; Okamura A
Nihon Shokakibyo Gakkai Zasshi; 1994 Mar; 91(3):267-78. PubMed ID: 7908344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
